LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Chemical Test Detects Counterfeit Malaria Drugs

By LabMedica International staff writers
Posted on 04 Aug 2014
Image: The Artesunate Field Test Kit (Photo courtesy of Oregon State University).
Image: The Artesunate Field Test Kit (Photo courtesy of Oregon State University).
A rapid, inexpensive and simple colorimetric-based testing kit for the detection of counterfeit anti-malaria drugs has been developed in order to preserve life and prevent the development of multidrug resistant malaria.

The assay is based on paper microfluidics which offers several advantages over conventional microfluidics, and has great potential to generate inexpensive, easy-to-use, rapid and disposable diagnostic devices and when widely used it could help save hundreds of thousands of lives.

Chemists at the Oregon State University (Corvallis, OR, USA) fabricated a microchip using Whatman filter paper or glass microfiber GF/B (Sigma Aldrich; St. Louis, MO,USA). The filter paper is cut into circular test pads using an 8-mm diameter hole-punch. They designed the paper microchip to enable fluid transport vertically by stacking the paper test pads. Each of the paper cut out has been pretreated by spotting them with different reagents and allowed to dry.

The paper test was divided into layers with the appropriate dried reagents, and the easily prepared sample solution will flow through the regions via capillary action in order to carry out the artesunate detection test. The artesunate sample can then be applied directly onto the test strip/device for measurement. The color will fully develop within minutes so that the user can determine whether artesunate is present in the drug formulation at a therapeutic dose or not. The kit provides a color-coded chart, similar to that accompanying pH paper, which is used to determine the relative concentration of artesunate in the tablet. The paper-based assay, together with the accompanying color chart provides a reliable semi-quantitative measurement of artesunate in a tablet. The rapid, simple, and inexpensive test is especially useful when used as a screening tool for counterfeits in remote areas.

Color measurement of each chip was obtained by using a camera phone application. A sample was applied to the paper chip and allowed to incubate for five minutes for color development. Analysis of the image was performed by measuring the Red, Green, Blue (RGB) value of each spot, and converted to average gray intensity. A single pill can be crushed, dissolved in water, and when a drop of the solution is placed on the paper, it turns yellow if the drug is present. The intensity of the color indicates the level of the drug, which can be compared to a simple color chart.

Vincent T. Remcho, PhD, a professor of chemistry and senior author of the study said, “There are laboratory methods to analyze medications such as this, but they often are not available or widely used in the developing world where malaria kills thousands of people every year. What we need are inexpensive, accurate assays that can detect adulterated pharmaceuticals in the field, simple enough that anyone can use them and our technology should provide that.” The study was published on June 27, 2014, in the journal Talanta.

Related Links:

Oregon State University
Sigma Aldrich


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more